Skip to content
ppharmaranks
Menu
Class IIIOngoing

Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) recall

FDA recall D-0223-2026 · initiated Nov 26, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Dec 17, 2025How we research

Winder Laboratories, LLC recalled Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) in Nov 2025 — an FDA Class III recall (D-0223-2026) because Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot 1312405; Exp 09/28/2027

Quantity recalled: 3,528 30 mL Bottles

Details

Product
Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01
Recalling company
Winder Labs LLC
Classification
Class III
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Nov 26, 2025
FDA report date
Dec 17, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) recalled?
Winder Laboratories, LLC recalled Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) in Nov 2025 — an FDA Class III recall (D-0223-2026) because Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why was Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) recalled?
Per the FDA enforcement record, the reason for recall D-0223-2026 was: Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
Is a recalled Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL) are affected?
Distributed: U.S. Nationwide. The recall covers these lots — Lot 1312405; Exp 09/28/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0223-2026.

Source: openFDA Drug Enforcement record D-0223-2026

← All drug recalls